Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home Delivery of Pemetrexed as Maintenance Treatment in Advanced Nonsquamous NSCLC
2011-000841-19Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Primary endpoint: Adherence to treatment administration at home. Started Jul 2011; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2011-000841-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000841-19.